Testosterone threshold – does one size fit all?

References

• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59
   PubMed Web of Science ®Google Scholar
• Martens H, Sheets P, Tenover J, et al. Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy. J Rheumatol 1994;21:1427–31
   PubMed Web of Science ®Google Scholar
• Aloisi AM, Aurilio C, Bachiocco V, et al. Endocrine consequences of opioid therapy. Psychoneuroendocrinology 2009;34:S162–8
   Google Scholar
• Salmimies P, Kockott G, Pirke KM, et al. Effects of testosterone replacement on sexual behavior in hypogonadal men. Arch Sex Behav 1982;11:345–53
   PubMed Web of Science ®Google Scholar
• Buena F, Swerdloff RS, Steiner BS, et al. Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 1993;59:1118–23
   PubMed Web of Science ®Google Scholar
• Finkelstein JS, Yu EW, Burnett-Bowie SA. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013;369:2457
   PubMedGoogle Scholar
• Swerdloff R, Wang C. Testosterone treatment of older men – why are controversies created? J Clin Endocrinol Metab 2011;96:62–5
   PubMedGoogle Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Baltimore Longitudinal Study of A. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724–31
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–35
   PubMed Web of Science ®Google Scholar
• Tancredi A, Reginster J-Y, Schleich F, et al. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004;151:355–60
   PubMed Web of Science ®Google Scholar
• Delhez M, Hansenne M, Legros J-J. Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology 2003;28:863–74
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. Aging Male 2013;16:143–50
   PubMed Web of Science ®Google Scholar
• Scovell JM, Ramasamy R, Wilken N, et al. Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400ng/dL. BJU Int 2014. [Epub ahead of print]. doi:10.1111/bju.12970
   Google Scholar
• Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 2005;63:381–94
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335–43
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 2001;281:E1172–81
   PubMed Web of Science ®Google Scholar
• Seftel AD, Mack RJ, Secrest AR, Smith TM. Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning. J Androl 2004;25:963–72
   PubMedGoogle Scholar
• Kelleher S, Conway AJ, Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004;89:3813–7
   PubMed Web of Science ®Google Scholar
• Lackner JE, Rücklinger E, Schatzl G, et al. Are there symptom-specific testosterone thresholds in aging men? BJU Int 2011;108:1310–5
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness1. Int J Androl 2003;26:76–83
   PubMedGoogle Scholar
• Paduch DA, Brannigan RE, Fuchs EF, et al. The laboratory diagnosis of testosterone deficiency. Urology 2014;83:980–8
   PubMed Web of Science ®Google Scholar
• Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121–30
   PubMed Web of Science ®Google Scholar
• Heaton JP. Hormone treatments and preventive strategies in the aging male: whom and when to treat? Rev Urol 2003;5:S16–S21
   Google Scholar
• Hellstrom WJg. Androgen deficiency and testosterone replacement: current controversies and strategies. New York: Springer; 2012
   Google Scholar
• Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011;165:675–85
   PubMed Web of Science ®Google Scholar
• Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013;11:108
   PubMed Web of Science ®Google Scholar
• Vigen R, O’Donnell CI, Barón AE, et al. ASsociation of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:1829–36
   PubMed Web of Science ®Google Scholar
• Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363:109–22
   PubMed Web of Science ®Google Scholar
• Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014;9:e85805
   PubMed Web of Science ®Google Scholar